
IndraLab
Statements
sparser
"To explore the role of USP35-FUCA1 axis in vivo, we subcutaneously inoculated the control (EV + shNC), USP35-overexpressed (USP35 + shNC), and USP35 overexpressed FUCA1-depleted (USP35 + shFUCA1-4) HT29 cells in the athymic nude mice, intraperitoneally injected water (H 2 O), single drug (OXA as a representative), or combined drugs (OXA + 5-FU) weekly into the mice, and routinely monitored the tumor growth."
reach
"In parallel with the in vitro data, USP35 overexpression weakened drug-induced cell apoptosis while knockdown of FUCA1 in USP35-overexpressed cells restored drug-induced cell apoptosis, suggesting that USP35 contributes to OXA/5-FU resistance through stabilizing FUCA1 in vivo (Fig. 6D and S13A–C)."
USP35 affects cell population proliferation
|
28
3
USP35 activates cell population proliferation.
|
20
USP35 activates cell population proliferation. 10 / 20
|
20
reach
"The results demonstrated that USP35 knockdown with siRNAs remarkably reduced cell proliferation and survival ability (Fig. S6 A-C), whereas overexpression of USP35 promoted cell proliferation and survival (Fig. S6 D-F), which is consistent with the findings that USP35 can promote mitotic progression 30.To further investigate whether the enzymatic activity of USP35 is required for its biological effects, we transfected GC cells with a WT-USP35 vector or USP35-C450A mutant (Fig. 5A) and performed Transwell and scratch wound healing assays."
USP35 inhibits cell population proliferation.
|
8
3
sparser
"To explore the role of USP35-FUCA1 axis in vivo, we subcutaneously inoculated the control (EV + shNC), USP35-overexpressed (USP35 + shNC), and USP35 overexpressed FUCA1-depleted (USP35 + shFUCA1-4) HT29 cells in the athymic nude mice, intraperitoneally injected water (H 2 O), single drug (OXA as a representative), or combined drugs (OXA + 5-FU) weekly into the mice, and routinely monitored the tumor growth."
USP35 affects ferroptosis
|
20
USP35 inhibits ferroptosis.
|
14
USP35 inhibits ferroptosis. 10 / 14
|
14
reach
"Despite this, the knockdown of USP35 resulted in increased Lipid ROS levels and inhibited the growth of TNBC cells MDA-MB-231 and SUM159PT (Supplementary Fig. 5B, 1G, 5C), whereas USP35 overexpression partially inhibited ferroptosis induced by Erastin in MDA-MB-231 cells (Supplementary Fig. 9)."
reach
"Furthermore, USP35 did not interact with BRD4 in TNBC cells (Supplementary Fig. 5D), suggesting that USP35 inhibited ferroptosis independent of the BRD4-SLC7A11 axis in TNBC although BRD4 and SLC7A11 mRNA levels were positively correlated (Supplementary Fig. 7B), which was different from in ER+ breast cancer (Fig. 4)."
USP35 activates ferroptosis.
|
6
USP35 activates ferroptosis. 6 / 6
|
6
reach
"Our results demonstrated that BRD4 inhibition with (+)-JQ-1 treatment significantly inhibited the ER+ breast tumors enhanced by USP35 overexpression, along with decrease of SLC7A11 protein level, and increase of 4-HNE protein levels (Fig. 7), supporting that BRD4 mediated USP35 inhibition of ferroptosis in ER+ breast tumors.Reported studies have shown SLC7A11 expression can be regulated at translational and post-translational levels ."
sparser
"Furthermore, USP35 did not interact with BRD4 in TNBC cells (Supplementary Fig. xref ), suggesting that USP35 inhibited ferroptosis independent of the BRD4-SLC7A11 axis in TNBC although BRD4 and SLC7A11 mRNA levels were positively correlated (Supplementary Fig. xref ), which was different from in ER+ breast cancer (Fig. xref )."
sparser
"Since USP35 also interacted with BRD4 (Fig. xref ), it is possible that BRD4 together with USP35 and/or ERα regulate the transcription of SLC7A11 , conferring resistance to ferroptosis in ER+ breast cancer cells, which could explain why BRD4 partially rescued SLC7A11 expression in USP35 knockdown ER+ breast cancer cells (Fig. xref )."
reach
"Given the diversity of its substrates, it will be important to investigate whether USP35 promotes HCC development by additional targets other than ABHD17C.ABHD17 depalmitoylases can regulate palmitoylation of N-RAS to change its subcellular localization, and selective inhibitor of ABHD17 proteins is reported to repress N-RAS signaling and impair acute myeloid leukemia cell growth [15, 16]."
sparser
"These findings not only expand our understanding of the mechanisms underlying the beneficial effects of hUC-MSC and hUC-MSC-EV in mitigating CIRI and the regulation of FUNDC1 metabolism but also highlight the USP35-FUNDC1 axis as a therapeutical target for the treatment of symptoms arising from CIRI."
reach
"Therefore, endogenous USP35 is not essential for the neuroprotective effects of hUC-MSCs and their EVs in this context.Notably, our study only revealed that overdosed exogenous USP35 encapsulated in hUC-MSC-EVs inhibits apoptosis and mitochondrial damage by stabilizing FUNDC1 in OGD/R-induced SH-SY5Y cells at the cellular level."
USP35 is modified
2
|
1
11
sparser
"Furthermore, USP35 did not interact with BRD4 in TNBC cells (Supplementary Fig. xref ), suggesting that USP35 inhibited ferroptosis independent of the BRD4-SLC7A11 axis in TNBC although BRD4 and SLC7A11 mRNA levels were positively correlated (Supplementary Fig. xref ), which was different from in ER+ breast cancer (Fig. xref )."
sparser
"Since USP35 also interacted with BRD4 (Fig. xref ), it is possible that BRD4 together with USP35 and/or ERα regulate the transcription of SLC7A11 , conferring resistance to ferroptosis in ER+ breast cancer cells, which could explain why BRD4 partially rescued SLC7A11 expression in USP35 knockdown ER+ breast cancer cells (Fig. xref )."
reach
"Our results demonstrated that BRD4 inhibition with (+)-JQ-1 treatment significantly inhibited the ER+ breast tumors enhanced by USP35 overexpression, along with decrease of SLC7A11 protein level, and increase of 4-HNE protein levels (Fig. 7), supporting that BRD4 mediated USP35 inhibition of ferroptosis in ER+ breast tumors.Reported studies have shown SLC7A11 expression can be regulated at translational and post-translational levels ."
USP35 affects apoptotic process
|
12
USP35 inhibits apoptotic process.
|
9
USP35 inhibits apoptotic process. 9 / 9
|
9
reach
"Therefore, endogenous USP35 is not essential for the neuroprotective effects of hUC-MSCs and their EVs in this context.Notably, our study only revealed that overdosed exogenous USP35 encapsulated in hUC-MSC-EVs inhibits apoptosis and mitochondrial damage by stabilizing FUNDC1 in OGD/R-induced SH-SY5Y cells at the cellular level."
USP35 activates apoptotic process.
|
3
reach
"We observed that USP35 overexpression markedly promoted tumor growth and drug resistance, but depleting FUCA1 in USP35-overexpressed cells reversed the tumor growth to the basal levels, and re-sensitized the tumors to the chemo-treatments, as indicated by representative images, tumor weight and growth curve (Fig. 6A–C)."
sparser
"USP35 can bind to CDH1 and restore Aurora B levels that have been reduced by CDH1-induced ubiquitination, suggesting that USP35 counteracts the APC CDH1 -mediated ubiquitination of Aurora B. This possibility supports the occurrence of mitotic defects in USP35-depleted cells, as dysregulated levels of Aurora B protein may interfere with the progression of mitosis."
sparser
"These findings not only expand our understanding of the mechanisms underlying the beneficial effects of hUC-MSC and hUC-MSC-EV in mitigating CIRI and the regulation of FUNDC1 metabolism but also highlight the USP35-FUNDC1 axis as a therapeutical target for the treatment of symptoms arising from CIRI."
USP35 affects Stomach Neoplasms
|
9
USP35 affects Neoplasm Invasiveness
|
9
sparser
"Therefore, to investigate the mode of deubiquitination of Snail1 by USP35, we co-transfected Flag-Snail1 with WT HA-Ub, K0 HA-Ub (with all lysine residues in Ub were mutated to arginine), or one among HA-Ub K6, K11, K27, K29, K33, K48, and K63 (in which all lysine residues except those at positions 6, 11, 27, 29, 33, 48, and 63, respectively, were replaced with arginine), together with empty vector or Myc-USP35, into HEK293T cells."
USP35 affects Carcinogenesis
|
8
USP35 affects immune response
|
7
USP35 inhibits immune response.
|
6
USP35 activates immune response.
|
1
USP35 activates immune response. 1 / 1
|
1
sparser
"FPN ubiquitination is required for its internalization and degradation, and Zhang et al identified the deubiquitinated role of USP35 in ovarian cancer cells. xref , xref Consistently, we found that USP35 directly interacted with FPN and functioned as a deubiquitinase to maintain its protein stability."
sparser
"FPN ubiquitination is required for its internalization and degradation, and Zhang et al identified the deubiquitinated role of USP35 in ovarian cancer cells. xref , xref Consistently, we found that USP35 directly interacted with FPN and functioned as a deubiquitinase to maintain its protein stability."
sparser
"Therefore, to investigate the mode of deubiquitination of Snail1 by USP35, we co-transfected Flag-Snail1 with WT HA-Ub, K0 HA-Ub (with all lysine residues in Ub were mutated to arginine), or one among HA-Ub K6, K11, K27, K29, K33, K48, and K63 (in which all lysine residues except those at positions 6, 11, 27, 29, 33, 48, and 63, respectively, were replaced with arginine), together with empty vector or Myc-USP35, into HEK293T cells."
sparser
"USP35 can bind to CDH1 and restore Aurora B levels that have been reduced by CDH1-induced ubiquitination, suggesting that USP35 counteracts the APC CDH1 -mediated ubiquitination of Aurora B. This possibility supports the occurrence of mitotic defects in USP35-depleted cells, as dysregulated levels of Aurora B protein may interfere with the progression of mitosis."
USP35 affects cell growth
|
6
USP35 activates cell growth.
|
4
USP35 inhibits cell growth.
|
2
USP35 affects Reactive Oxygen Species
|
6
USP35 decreases the amount of Reactive Oxygen Species.
|
4
USP35 inhibits Reactive Oxygen Species.
|
2
sparser
"The production lots presented in Table xref were also analysed for the presence of the bacterial lipopolysaccharide (LPS), which is a membrane component of Gram‐negative bacteria that could act as endotoxin, according to the US Pharmacopeia method based on the use of amoebocyte lysate from the horseshoe crab (USP35‐NF30, xref ) and all the samples analysed tested negative."
sparser
"Functionally, both ABIN-2 and USP35 could inhibit TNFα-induced NF-κB activation and overexpression of ABIN-2 alleviated USP35-loss induced activation of NF-κB. Collectively, our data indicated that miR let-7a-regulated USP35 can inhibit NF-κB activation by deubiquitination and stabilization of ABIN-2 protein and eventually inhibit cell proliferation."
USP35 affects Interferon
|
6
USP35 inhibits Interferon.
|
3
USP35 inhibits Interferon. 3 / 3
|
3
reach
"Our findings further underscore the role of USP35 in negatively regulating the MAVS-TBK1-IRF3 signaling pathway, and the knockdown of USP35 enhances type I interferon and inflammation-related factor expression in response to cytoplasmic RNA virus or RNA analog.MAVS is an essential adapter protein in the RLR pathway and plays a key role in the production of type I IFN [29]."
USP35 decreases the amount of Interferon.
|
2
USP35 decreases the amount of Interferon. 2 / 2
|
2
reach
"Knockdown of USP35 combined with oncolytic virus significantly promotes the immune infiltration of CD8+ T cells and the release of IFNβ and inflammatory factors CXCL10 and CCL5, ultimately inhibiting the growth of malignant melanoma, Overall, our findings identify USP35 as a previously undescribed regulator of MAVS pathway, and targeting USP35 provides a strategy for immunotherapy of malignant melanoma."
USP35 increases the amount of Interferon.
|
1
USP35 increases the amount of Interferon. 1 / 1
|
1
sparser
"The production lots presented in Table xref were also analysed for the presence of the bacterial lipopolysaccharide (LPS), which is a membrane component of Gram‐negative bacteria that could act as endotoxin, according to the US Pharmacopeia method based on the use of amoebocyte lysate from the horseshoe crab (USP35‐NF30, xref ) and all the samples analysed tested negative."
USP35 affects cell death
|
5
USP35 activates cell death.
|
3
USP35 inhibits cell death.
|
2
|
5
Infections affects USP35
|
5
Infections increases the amount of USP35.
|
3
Infections inhibits USP35.
|
1
Infections inhibits USP35. 1 / 1
|
1
Infections activates USP35.
|
1
Infections activates USP35. 1 / 1
|
1
USP35 affects activation
|
4
USP35 affects Neoplasm Metastasis
|
4
USP35 affects autophagy of mitochondrion
|
3
USP35 affects Histone_H3
|
2
1
USP35 phosphorylates Histone_H3.
|
1
USP35 phosphorylates Histone_H3. 1 / 1
|
1
USP35 increases the amount of Histone_H3.
|
1
USP35 increases the amount of Histone_H3. 1 / 1
|
1
USP35 decreases the amount of Histone_H3.
|
1
USP35 decreases the amount of Histone_H3. 1 / 1
|
1
reach
"Therefore, we performed a series of functional studies under the regulation of USP35-FUCA1 axis, aiming to better understand the role of FUCA1 in cancers.In the present study, we first demonstrated that USP35 promoted CRC cell proliferation and resistance to the drugs (oxaliplatin and 5-fluorouracil) routinely used in the CRC clinic."
Aurora subfamily affects USP35
|
2
USP35 affects wound healing
|
2
USP35 affects signal transduction
|
2
USP35 affects paclitaxel
|
2
USP35 inhibits paclitaxel.
|
1
USP35 inhibits paclitaxel. 1 / 1
|
1
USP35 activates paclitaxel.
|
1
USP35 activates paclitaxel. 1 / 1
|
1
USP35 affects oxaliplatin
|
2
USP35 affects malonaldehyde
|
2
USP35 inhibits malonaldehyde.
|
1
USP35 inhibits malonaldehyde. 1 / 1
|
1
USP35 decreases the amount of malonaldehyde.
|
1
USP35 decreases the amount of malonaldehyde. 1 / 1
|
1
USP35 affects growth
|
2
|
2
USP35 activates epithelial to mesenchymal transition. 2 / 2
|
2
USP35 affects biological role
|
2
USP35 inhibits biological role.
|
1
USP35-C345A inhibits biological role. 1 / 1
|
1
USP35 activates biological role.
|
1
USP35 activates biological role. 1 / 1
|
1
USP35 affects aurora subfamily
|
2
USP35 affects OGD/R
|
2
USP35 affects Iron Overload
|
2
USP35 affects CPC proteins
|
2
USP35 increases the amount of CPC proteins.
|
1
reach
"Indeed, USP35 knockdown could not disrupt the levels of other CPC proteins, such as INCENP or Survivin, indicating that USP35 does not affect other CPC proteins and may only have an effect on Aurora B. Based on these data, we concluded that USP35 induced deubiquitination of Aurora B could affect its downstream signaling, which is required for faithful mitotic progression."
USP35 binds CPC proteins.
|
1
USP35 affects Breast Neoplasms
|
2
USP35 activates Breast Neoplasms. 2 / 2
|
2
reach
"Our results demonstrated that BRD4 inhibition with (+)-JQ-1 treatment significantly inhibited the ER+ breast tumors enhanced by USP35 overexpression, along with decrease of SLC7A11 protein level, and increase of 4-HNE protein levels (Fig. 7), supporting that BRD4 mediated USP35 inhibition of ferroptosis in ER+ breast tumors.Reported studies have shown SLC7A11 expression can be regulated at translational and post-translational levels ."
USP35 affects 5-fluorouracil
|
2
USP35 affects (E)-4-hydroxynon-2-enal
|
2
USP35 increases the amount of (E)-4-hydroxynon-2-enal.
|
1
USP35 increases the amount of (E)-4-hydroxynon-2-enal. 1 / 1
|
1
USP35 decreases the amount of (E)-4-hydroxynon-2-enal.
|
1
USP35 decreases the amount of (E)-4-hydroxynon-2-enal. 1 / 1
|
1
Ferritin affects USP35
|
1
Digitonin affects USP35
|
1
USP35 affects ubiquitination
|
1
USP35 affects type I interferons
|
1
|
1
USP35 affects sensitivity cisplatin-induced apoptosis
|
1
USP35 affects response to xenobiotic stimulus
|
1
USP35 activates response to xenobiotic stimulus. 1 / 1
|
1
reach
"We observed that USP35 overexpression markedly promoted tumor growth and drug resistance, but depleting FUCA1 in USP35-overexpressed cells reversed the tumor growth to the basal levels, and re-sensitized the tumors to the chemo-treatments, as indicated by representative images, tumor weight and growth curve (Fig. 6A–C)."
USP35 affects regulation of cell cycle
|
1
USP35 inhibits regulation of cell cycle. 1 / 1
|
1
USP35 affects pathway
|
1
USP35 affects miRNA-140-3p
|
1
USP35 affects mevalonate
|
1
USP35 activates mevalonate. 1 / 1
|
1
USP35 affects metabolic process
|
1
USP35 activates metabolic process. 1 / 1
|
1
USP35 affects localization
|
1
USP35 inhibits localization. 1 / 1
|
1
USP35 affects hepatocellular carcinoma
|
1
USP35 activates hepatocellular carcinoma. 1 / 1
|
1
USP35 affects glutathione
|
1
USP35 decreases the amount of glutathione. 1 / 1
|
1
USP35 affects ferritin
|
1
USP35 affects endoplasmic-reticulum-stress-induced apoptosis
|
1
USP35 affects degradation
|
1
USP35 affects cytokinesis
|
1
USP35 activates cytokinesis. 1 / 1
|
1
USP35 affects cisplatin-induced cell apoptosis
|
1
USP35 affects cisplatin-induced apoptosis
|
1
USP35 affects cell cycle
|
1
USP35 activates cell cycle. 1 / 1
|
1
reach
"The results from this study suggest that USP35 overexpression in ER+ breast cancer may confer resistance to ferroptotic insult by elevating GSH level via the BRD4-SLC7A11 axis.Our published work indicates that USP35 promotes the growth of ER+ breast cancer cells in vitro and in vivo, at least in part by affecting the G1 phase of cell cycle ."
USP35 affects cGAS-STING-interferon
|
1
reach
"This may suggest that USP35 plays additional roles in the cytosol to delay PARK2 mediated mitophagy.Overexpressing USP30 but not USP35 delays PARK2 recruitmentIn cells with a healthy mitochondrial network, PARK2 is diffused in the cytosol and not on mitochondria.9 However, following mitophagy activation by CCCP treatment, PARK2 is recruited to mitochondria within 1 h."
USP35 affects RIG-I-MAVS
|
1
USP35 affects PRAD
|
1
USP35 affects OMM proteins
|
1
USP35 affects NSCLC
|
1
USP35 affects MOM proteins
|
1
USP35 affects KIRC
|
1
USP35 affects K63
|
1
reach
"The results from this study suggest that USP35 overexpression in ER+ breast cancer may confer resistance to ferroptotic insult by elevating GSH level via the BRD4-SLC7A11 axis.Our published work indicates that USP35 promotes the growth of ER+ breast cancer cells in vitro and in vivo, at least in part by affecting the G1 phase of cell cycle ."
USP35 affects Endoplasmic Reticulum Stress
|
1
USP35 activates Endoplasmic Reticulum Stress. 1 / 1
|
1
USP35 affects ER-stress-induced cell apoptosis
|
1
USP35 affects Deterin
|
1
USP35 affects DNA-templated transcription
|
1
USP35 activates DNA-templated transcription. 1 / 1
|
1
USP35 affects Cucumber peeling cupredoxin
|
1
USP35 affects Cell Survival
|
1
USP35 activates Cell Survival. 1 / 1
|
1
USP35 affects Carcinoma, Hepatocellular
|
1
USP35 activates Carcinoma, Hepatocellular. 1 / 1
|
1
USP35 affects BRD4-SLC7A11
|
1
reach
"Furthermore, USP35 did not interact with BRD4 in TNBC cells (Supplementary Fig. 5D), suggesting that USP35 inhibited ferroptosis independent of the BRD4-SLC7A11 axis in TNBC although BRD4 and SLC7A11 mRNA levels were positively correlated (Supplementary Fig. 7B), which was different from in ER+ breast cancer (Fig. 4)."
reach
"Inactivation of USP35 in a zebrafish model of BBS4 ciliopathy, rescues different ciliary defects, such as impaired convergent and extension movements during gastrulation, renal tubule convolution and retinal degeneration, thus ameliorating the phenotype(s) of BBS4-depleted animals (Tsai et al., 2019)."
USP35 affects B16F10
|
1
|
1
USP35 activates 4-(ethoxymethylene)-2-phenyloxazol-5-one. 1 / 1
|
1
MAVS affects K63
|
1
K63 affects USP35
|
1
Cucumber peeling cupredoxin affects USP35
|
1
CPC proteins affects USP35
|
1
BRD4 inhibitor affects USP35
|
1
17alpha-ethynylestradiol affects USP35
|
1
17alpha-ethynylestradiol increases the amount of USP35. 1 / 1
|
1